107 related articles for article (PubMed ID: 11984539)
1. Leptin and liver fibrosis: a matter of fat.
Marra F
Gastroenterology; 2002 May; 122(5):1529-32. PubMed ID: 11984539
[No Abstract] [Full Text] [Related]
2. Adipogenesis and obesity: rounding out the big picture.
Spiegelman BM; Flier JS
Cell; 1996 Nov; 87(3):377-89. PubMed ID: 8898192
[No Abstract] [Full Text] [Related]
3. Glomerulosclerosis, tubulointerstitial fibrosis, and obstructive uropathy in PEPCK-TGF-beta1 transgenic mice.
Kopp JB
Am J Kidney Dis; 1999 Jul; 34(1):177-83. PubMed ID: 10401036
[No Abstract] [Full Text] [Related]
4. Leptin, liver, and obese mice--fibrosis in the fat lane.
Anania FA
Hepatology; 2002 Jul; 36(1):246-8. PubMed ID: 12085371
[No Abstract] [Full Text] [Related]
5. The roles of receptor abnormalities in the pathogenesis and chronic complications of type 2 diabetes mellitus.
Xiong W; Gray JD
Clin Invest Med; 1999 Jun; 22(3):85-105. PubMed ID: 10410831
[TBL] [Abstract][Full Text] [Related]
6. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis.
Fiorucci S; Antonelli E; Rizzo G; Renga B; Mencarelli A; Riccardi L; Orlandi S; Pellicciari R; Morelli A
Gastroenterology; 2004 Nov; 127(5):1497-512. PubMed ID: 15521018
[TBL] [Abstract][Full Text] [Related]
7. [Effects of antisense transforming growth factor beta receptor-II (TGFbetaRII) expressing plasmid on experimental liver fibrosis].
Jiang W; Wang JY; Yang CQ; Liu WB; Wang YQ; He BM
Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):137-40. PubMed ID: 15059294
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional roles for transforming growth factor-beta 1.
Fausto N
Lab Invest; 1991 Nov; 65(5):497-9. PubMed ID: 1753699
[No Abstract] [Full Text] [Related]
9. Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis.
Fiorucci S; Rizzo G; Antonelli E; Renga B; Mencarelli A; Riccardi L; Morelli A; Pruzanski M; Pellicciari R
J Pharmacol Exp Ther; 2005 Oct; 315(1):58-68. PubMed ID: 15980055
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion.
Wang MY; Koyama K; Shimabukuro M; Mangelsdorf D; Newgard CB; Unger RH
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11921-6. PubMed ID: 9751766
[TBL] [Abstract][Full Text] [Related]
11. Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis.
Otte C; Otte JM; Strodthoff D; Bornstein SR; Fölsch UR; Mönig H; Kloehn S
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):10-7. PubMed ID: 14758566
[TBL] [Abstract][Full Text] [Related]
12. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice.
Saxena NK; Ikeda K; Rockey DC; Friedman SL; Anania FA
Hepatology; 2002 Apr; 35(4):762-71. PubMed ID: 11915021
[TBL] [Abstract][Full Text] [Related]
13. Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis.
Dhillon H; Zigman JM; Ye C; Lee CE; McGovern RA; Tang V; Kenny CD; Christiansen LM; White RD; Edelstein EA; Coppari R; Balthasar N; Cowley MA; Chua S; Elmquist JK; Lowell BB
Neuron; 2006 Jan; 49(2):191-203. PubMed ID: 16423694
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats.
Nakamura T; Sakata R; Ueno T; Sata M; Ueno H
Hepatology; 2000 Aug; 32(2):247-55. PubMed ID: 10915731
[TBL] [Abstract][Full Text] [Related]
15. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice.
Clouthier DE; Comerford SA; Hammer RE
J Clin Invest; 1997 Dec; 100(11):2697-713. PubMed ID: 9389733
[TBL] [Abstract][Full Text] [Related]
16. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin.
Kamada Y; Tamura S; Kiso S; Matsumoto H; Saji Y; Yoshida Y; Fukui K; Maeda N; Nishizawa H; Nagaretani H; Okamoto Y; Kihara S; Miyagawa J; Shinomura Y; Funahashi T; Matsuzawa Y
Gastroenterology; 2003 Dec; 125(6):1796-807. PubMed ID: 14724832
[TBL] [Abstract][Full Text] [Related]
17. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.
Matsusue K; Haluzik M; Lambert G; Yim SH; Gavrilova O; Ward JM; Brewer B; Reitman ML; Gonzalez FJ
J Clin Invest; 2003 Mar; 111(5):737-47. PubMed ID: 12618528
[TBL] [Abstract][Full Text] [Related]
18. [Leptin and liver fibrosis].
Yin CH; Wang BE; Ma H; Jia JD; Shen FJ
Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):60-1. PubMed ID: 12546755
[No Abstract] [Full Text] [Related]
19. [Insulin resistance, role of leptin and leptin receptor].
Shintani M; Ogawa Y; Nakao K
Nihon Rinsho; 2000 Feb; 58(2):327-32. PubMed ID: 10707553
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Tyr to Phe and fa/fa leptin receptor mutations in the PC12 cell line.
Eyckerman S; Waelput W; Verhee A; Broekaert D; Vandekerckhove J; Tavernier J
Eur Cytokine Netw; 1999 Dec; 10(4):549-56. PubMed ID: 10586122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
